# FDA Inspection 1206484 - Cohance Lifesciences Limited - April 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/64adc54e-0adf-4c50-8656-4cc992d78159
Source feed: FDA_Inspections

> FDA Inspection 1206484 for Cohance Lifesciences Limited on April 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206484
- Company Name: Cohance Lifesciences Limited
- Inspection Date: 2023-04-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1031029 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/275ee29a-fa55-477c-b5dc-e48eedb0cd6e)
- [FDA Inspection 896853 - 2014-08-23](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/29e26c34-548e-458e-b408-2451490dd6ca)
- [FDA Inspection 683987 - 2010-09-18](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/b793a824-6644-4aa3-ad0d-0ed93a8c331e)

Company: https://www.keypedia.com/companies/cohance-lifesciences-limited/f0cc5816-deaa-4973-9791-36ef5ebf2e0d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c